IfPA’s Patient Access Policy Blog

Can Yoga Solve America’s Opioid Abuse Crisis?

Could the solution to America’s opioid overdose crisis be as close as the nearest yoga studio?   A new study from the VA San Diego

Read More

New “Fast Facts” Examines Issue of Co-Pay Coupons

Are coupons that help patients afford their co-pays a help – or a hindrance – in the age of innovative but costly prescription medications?  A

Read More

Physicians Collaborate on Medicare Policy for Parkinson’s Patients

By Stuart Isaacson, MD Most all of us know someone living in a long-term care facility – a friend, a former neighbor, a family member.

Read More

IfPA Paper Weighs Access to Hepatitis C Cures for Prisoners

Nearly one in five Americans with hepatitis C spends time behind bars each year, making the prison system an opportune environment to test and cure

Read More

ICER Report Could Intensify Barriers for Heart Patients

Accessing innovative cardiovascular drugs may soon get harder. A new publication from the Institute for Clinical and Economic Review, a drug price analysis group, assigns

Read More

Experts Envision “Precision” Benefit Design

Health plans often use different levels of cost sharing to drive patients toward one medication over another. But is this practice fair, ethical or effective

Read More

Health Plan Coverage for Biosimilars Raises Questions

Health plans are embracing biosimilars, a new Avalere Health study reveals.  Eighty-one percent of health plans now cover at least one of the two biosimilars

Read More

Cancer Moonshot: One Year Later

It’s been over a year since the launch of former vice president Joe Biden’s Cancer Moonshot, designed to spur innovation and encourage collaboration on finding

Read More

Access Barriers Loom for Movement Disorder Patients

Long-awaited treatment for a movement disorder known as tardive dyskinesia could remain out of reach – unless an upcoming cost-effectiveness analysis acknowledges its value to

Read More

Awareness Month Highlights Migraine’s Impact, Lack of Treatments

Some wore shades, others “showed purple.”  But advocates across the board used June’s Migraine & Headache Awareness Month to draw attention to a condition whose

Read More
Back to Top